FIELD: medicine; pharmacology.
SUBSTANCE: claimed group of inventions relates to the field of medicine and pharmacology and is a combination for the treatment of vertigo and dizziness, cerebellar ataxia and familial ataxia, containing in effective amounts acetylleucine and at least one substance selected from the group including betahistine, buspirone, choline alfoscerate, citicoline or their pharmaceutically acceptable salt, pharmaceutical composition, and a kit for treating vertigo and dizziness, cerebellar ataxia and familial ataxia, and their use for the treatment of vertigo and dizziness, cerebellar ataxia and familial ataxia.
EFFECT: claimed group of inventions provides high efficacy for treating vertigo and dizziness, cerebellar ataxia, familial ataxia due to the synergistic effect, as well as expanding the arsenal of tools for treating vertigo and dizziness, cerebellar ataxia, and family ataxia.
15 cl, 15 tbl, 1 ex
Authors
Dates
2019-02-21—Published
2017-12-01—Filed